MOOV yields 20000000.00% · PFE yields 6.20%● Live data
📍 MOOV pulled ahead of the other in Year 1
Combined, MOOV + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MOOV + PFE for your $10,000?
Moove Lubricants Holdings engages in the formulation, manufacturing, distribution, marketing, selling, and servicing of lubricant products in South America, North America, and Europe. It offers a range of lubricants, including engine oils; automotive and industrial fluids; special application products, such as greases, cutting oils, insulating oils, process oils, and car care products; and higher value-added synthetic oils. The company also provides customized solutions, such as condition monitoring, oil and filter changes, equipment upgrades, storage, handling, and other technical services. It serves industrial, consumer, and commercial channels, including passenger and commercial vehicles, marine, aviation, industrial equipment, and manufacturing. The company was founded in 2008 and is based in São Paulo, Brazil. Moove Lubricants Holdings operates as a subsidiary of Cosan S.A.
Full MOOV Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.